Bristol-Myers Squibb 2018 Golden Ticket Program Official Rules


The Bristol-Myers Squibb Golden Ticket Program (“Program”) is a contest that awards two  laboratory bench spots (comprised of one year of laboratory space for biomedical research at LabCentral in Cambridge, Massachusetts) to two innovative biotech start-ups pursuing research in the fields of Oncology, Immunology, Cardiovascular, or Fibrosis (“Award”) that best meet the judging criteria of the Program, or, in the sole discretion of the Judges, the one innovative biotech start-up that best meets the judging criteria will be awarded two laboratory bench spots at LabCentral.

1.  Sponsor 

Triangle Icon

2. Sponsor’s Relationship to LabCentral

Triangle Icon

3. Eligibility 

Triangle Icon

4. Applications for Golden Ticket Program

Triangle Icon

5. 2018 Application Period 

Triangle Icon

6. Judging Criteria and Judges

Triangle Icon

7. Awards

Triangle Icon

8. Notification and Conditions of Award

Triangle Icon

9. Restrictions on Content of Application

Triangle Icon

10. Ownership and Legal Right to the Research, Inventions, Other Materials Described and Embodied by Application

Triangle Icon

11. Grant of Licenses and Right to Use

Triangle Icon

12. Limitation of Liability, Waivers and Releases

Triangle Icon

13. Conditions of Acceptance of Award

Triangle Icon

14. Operation of Program by Sponsor

Triangle Icon